Effects of acute pramipexole on preference for gambling-like schedules of reinforcement in rats

Psychopharmacology

Volumn 213, Issue 1, 2011, Pages 11-18

  Johnson, Patrick S ^a   Madden, Gregory J ^a   Brewer, Adam T ^a   Pinkston, Jonathan W ^a   Fowler, Stephen C ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Dopamine agonist; Gambling; Impulsive behavior; Parkinson's disease; Pramipexole; Rat

Indexed keywords

PRAMIPEXOLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CONTROL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FORCED CHOICE METHOD; LOW DRUG DOSE; MALE; NONHUMAN; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; BENZOTHIAZOLES; CHOICE BEHAVIOR; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMBLING; MALE; RATS; RATS, WISTAR; REINFORCEMENT SCHEDULE;

EID: 78651259628     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-2006-5     Document Type: Article

References (40)

1. R Bakeman 2005 Recommended effect size statistics for repeated measures designs Behav Res Meth 37 379 384
2. V Boulougouris A Castañé TW Robbins 2009 Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior Psychopharmacology (Berl) 202 611 620 1:CAS:528:DC%2BD1cXht1aisLfF 10.1007/s00213-008-1341-2
3. ME Breuer L Groenink RS Oosting E Buerger M Korte B Ferger, et al. 2009 Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats Eur J Pharmacol 616 134 140 1:CAS:528:DC%2BD1MXptlans70%3D 10.1016/j.ejphar.2009.06. 029 19549514
4. PL Brown HM Jenkins 1968 Autoshaping of the pigeon's key-peck J Exp Anal Behav 11 1 8 1:CAS:528:DyaF1cXks12rs74%3D 10.1901/jeab.1968.11-1 5636851
5. GT Collins AH Newman P Grundt KC Rice SM Husbands C Chauvignac, et al. 2007 Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists Psychopharmacology (Berl) 193 159 170 1:CAS:528: DC%2BD2sXntFGqt7k%3D 10.1007/s00213-007-0766-3 (Pubitemid 47025018)
6. 3 receptor in rats and mice J Pharmacol Exp Ther 329 210 217 1:CAS:528:DC%2BD1MXksVKnu78%3D 10.1124/jpet.108.144048 19136638
7. R Cools L Altamirano M D'Esposito 2006 Reversal learning in Parkinson's disease depends on medication status and outcome valence Neuropsychologia 44 1663 1673 10.1016/j.neuropsychologia.2006.03.030 16730032 (Pubitemid 43928015)
8. JR Cornelius M Tippmann-Peikert NL Slocumb CF Frerichs MH Silber 2010 Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study Sleep 33 81 87 20120624
9. MH Corrigan AQ Denahan CE Wright RJ Ragual DL Evans 2000 Comparison of pramipexole, fluoxetine, and placebo in patients with major depression Depress Anxiety 11 58 65 1:STN:280:DC%2BD3c3nt1Cisg%3D%3D 10.1002/(SICI)1520-6394(2000) 11:2<58::AID-DA2>3.0.CO;2-H 10812530 (Pubitemid 30228411)
10. D Crockford J Quickfall S Currie S Furtado O Suchowersky N el-Guebaly 2008 Prevalence of problem and pathological gambling in Parkinson's disease J Gambl Stud 24 411 422 10.1007/s10899-008-9099-3 18561000
11. ML Dodd KJ Klos JH Bower YE Geda KA Josephs JE Ahlskog 2005 Pathological gambling caused by drugs used to treat Parkinson's disease Arch Neurol 62 1377 1381 10.1001/archneur.62.9.noc50009 16009751 (Pubitemid 41352054)
12. ED Driver-Dunckley J Samanta M Stacy 2003 Pathological gambling associated with dopamine agonist therapy in Parkinson's disease Neurology 61 422 423 1:STN:280:DC%2BD3sznslyjsQ%3D%3D 12913220
13. ED Driver-Dunckley BN Noble JG Hentz VG Evidente JN Caviness J Parish, et al. 2007 Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome Clin Neuropharmacol 30 249 255 1:CAS:528: DC%2BD2sXhtFSntb7M 10.1097/wnf.0b013e31804c780e 17909302 (Pubitemid 47511504)
14. DP Field F Tonneau W Ahearn PN Hineline 1996 Preference between variable-ratio and fixed-ratio schedules: local and extended relations J Exp Anal Behav 66 283 295 1:STN:280:DyaK2s%2FotVShtw%3D%3D 10.1901/jeab.1996.66-283 8921612
15. NA Fineberg MN Potenza SR Chamberlain HA Berlin L Menzies A Bechara, et al. 2010 Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review Neuropsychopharmacology 35 591 604 10.1038/npp.2009.185 19940844
16. MJ Frank J Samanta AA Moustafa SJ Sherman 2007 Hold your horses: impulsivity, deep brain stimulation, and medication in Parkinsonism Science 318 1309 1312 1:CAS:528:DC%2BD2sXhtlGmur7P 10.1126/science.1146157 17962524 (Pubitemid 350172897)
17. N Giladi N Weitzman S Schreiber H Shabtai C Peretz 2007 New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset J Psychopharmacol 21 501 506 10.1177/ 0269881106073109 17446202 (Pubitemid 47106924)
18. G Giovannoni JD O'Sullivan K Turner AJ Manson AJ Lees 2000 Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies J Neurol Neurosurg Psychiatry 68 423 428 1:STN:280:DC%2BD3c7ptlOisQ%3D%3D 10.1136/jnnp.68.4.423 10727476 (Pubitemid 30248740)
19. JE Grant L Schreiber BL Odlaug SW Kim 2010 Pathologic gambling and bankruptcy Compr Psychiatry 51 115 120 10.1016/j.comppsych.2009.04.002 20152290
20. KA Grosset G Macphee G Pal D Stewart A Watt J Davie, et al. 2006 Problematic gambling on dopamine agonists: not such a rarity Mov Disord 21 2206 2208 10.1002/mds.21110 17013907 (Pubitemid 46140438)
21. DM Haluk SB Floresco 2009 Ventral striatal dopamine modulation of different forms of behavioral flexibility Neuropsychopharmacology 34 2041 2052 1:CAS:528:DC%2BD1MXnsFSisr4%3D 10.1038/npp.2009.21 19262467
22. A Hamidovic UJ Kang H de Wit 2008 Effects of low to moderate doses of pramipexole on impulsivity and cognition in healthy volunteers J Clin Psychopharmacol 28 45 51 1:CAS:528:DC%2BD1cXnsFOitg%3D%3D 10.1097/jcp. 0b013e3181602fab 18204340
23. AJ Holman 2009 Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia J Gambl Stud 25 425 431 10.1007/s10899-009-9123-2 19241148
24. SR Hursh 1984 Behavioral economics J Exp Anal Behav 42 435 452 1:STN:280:DC%2BC3cnitlGitQ%3D%3D 10.1901/jeab.1984.42-435 16812401
25. KJ Klos JH Bower KA Josephs JY Matsumoto JE Ahlskog 2005 Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy Parkinsonism Relat Disord 11 381 386 10.1016/j.parkreldis.2005.06.005 16109498 (Pubitemid 41317806)
26. T Kvernmo S Härtter E Bürger 2006 A review of the receptor-binding and pharmacokinetic properties of dopamine agonists Clin Ther 28 1065 1078 1:CAS:528:DC%2BD28XhtVGmsrnO 10.1016/j.clinthera.2006.08.004 16982285 (Pubitemid 44374749)
27. M Lader 2008 Antiparkinsonian medication and pathological gambling CNS Drugs 22 407 416 1:CAS:528:DC%2BD1cXmvFSitrc%3D 10.2165/00023210-200822050-00004 18399709 (Pubitemid 351508124)
28. 3 preferring agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats Eur Neuropsychopharmacol 8 113 120 1:CAS:528:DyaK1cXhvFGqsb8%3D 10.1016/S0924- 977X(97)00054-0 9619689 (Pubitemid 28210337)
29. GJ Madden PS Johnson AT Brewer JW Pinkston SC Fowler 2010 Effects of pramipexole on impulsive choice in male Wistar rats Exp Clin Psychopharmacol 18 267 276 1:CAS:528:DC%2BC3cXptV2lt7s%3D 10.1037/a0019244 20545391
30. A McKeon KA Josephs KJ Klos K Hecksel JH Bower MJ Bostwick, et al. 2007 Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy Parkinsonism Relat Disord 13 516 519 10.1016/j.parkreldis.2007.04.004 17544807 (Pubitemid 350102309)
31. MJ Millan L Seguin A Gubert D Cussac M Brocco 2004 The role of dopamine D3 compared to D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats Psychopharmacology (Berl) 174 341 357 1:CAS:528:DC%2BD2cXls1antr8%3D 10.1007/s00213-003-1770-x
32. JA Molina MJ Saínz-Artiga A Fraile FJ Jiménez- Jiménez C Villanueva M Ortí-Pareja, et al. 2000 Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment? Mov Disord 15 869 872 1:STN:280:DC%2BD3cvlt1yisw%3D%3D 10.1002/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I 11009192
33. RP Munhoz G Fabiani N Becker HA Teive 2009 Increased frequency and range of sexual behavior in a patient with Parkinson's disease after use of pramipexole: a case report J Sex Med 6 1177 1180 1:CAS:528:DC%2BD1MXltFCgt70%3D 10.1111/j.1743-6109.2008.00861.x 18466265
34. MJ Nirenberg C Waters 2006 Compulsive eating and weight gain related to dopamine agonist use Mov Disord 21 524 529 10.1002/mds.20757 16261618
35. 3 agonists reduces spontaneous and dopamine-induced locomotion Pharmacol Biochem Behav 67 637 645 1:CAS:528:DC%2BD3MXnslSmsw%3D%3D 10.1016/S0091-3057(00)00406-8 11164096 (Pubitemid 32103576)
36. DA Pizzagalli AE Evins EC Schetter MJ Frank PE Pajtas DL Santesso, et al. 2008 Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness Psychopharmacology (Berl) 196 221 232 1:CAS:528: DC%2BD1cXpsF2ksA%3D%3D 10.1007/s00213-007-0957-y
37. J Riba UM Krämer M Heldmann S Richter TF Münte 2008 Dopamine agonist increases risk taking but blunts reward-related brain activity PLoS ONE 3 e2479 10.1371/journal.pone.0002479 18575579
38. P Sokoloff B Giros M Martres M Bouthenet J Schwartz 1990 Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics Nature 347 146 151 1:CAS:528:DyaK3MXhsFyjtrg%3D 10.1038/347146a0 1975644 (Pubitemid 20315872)
39. V Voon B Reynolds C Brezing C Gallea M Skaljic V Ekanayake, et al. 2010 Impulsive choice and response in dopamine agonist-related impulse control behaviors Psychopharmacology (Berl) 207 645 659 1:CAS:528:DC%2BD1MXhsVOgtLbI 10.1007/s00213-009-1697-y
40. CA Zarate Jr JL Payne J Singh JA Quiroz DA Luckenbaugh KD Denicoff, et al. 2004 Pramipexole for bipolar II depression: a placebo-controlled proof of concept study Biol Psychiatry 56 54 60 1:CAS:528:DC%2BD2cXlt1ams7o%3D 10.1016/j.biopsych.2004.03.013 15219473 (Pubitemid 38813406)